DRACP04373 |
Fellutamide D |
NXL |
3 |
Fungi |
DRACP04391 |
Phibilin |
RGDILKRWAGHFSKLL |
16 |
Synthetic |
DRACP04392 |
Nigrocin-PN |
GLLGKILGAGKKVLCGVSGLC |
21 |
Animalia |
DRACP04393 |
Nigrocin-PN [C15,21L] |
GLLGKILGAGKKVLLGVSGLL |
21 |
Synthetic |
DRACP04394 |
Nigrocin-PN (1-14) |
GLLGKILGAGKKVL |
14 |
Synthetic |
DRACP04419 |
|
WSKKWKW |
7 |
Synthetic |
DRACP04420 |
|
WSRRWRW |
7 |
Synthetic |
DRACP04421 |
|
WSRKWKW |
7 |
Synthetic |
DRACP04422 |
|
WSKKWKKKWKW |
11 |
Synthetic |
DRACP04423 |
|
WSRRWRRRWRW |
11 |
Synthetic |
DRACP04424 |
|
WSRKWKRKWKW |
11 |
Synthetic |
DRACP04426 |
Cordycommunin |
AAQYVXX |
7 |
Fungi |
DRACP04438 |
MAF-1A derived peptide Mt6 |
KKFKKTAKWLIKSAWLLLKSLALKMK |
26 |
Synthetic |
DRACP04439 |
MAF-1A derived peptide D-Mt6 |
kkfkktakwliksawlllkslalkmk |
26 |
Synthetic |
DRACP04521 |
Ocellatin-3N [D4K] |
GIFKVLKNLAKGVITSLAS |
19 |
Synthetic |
DRACP04522 |
Ocellatin-3N [A18K] |
GIFDVLKNLAKGVITSLKS |
19 |
Synthetic |
DRACP04523 |
Ocellatin-3N [D4K,A18K] |
GIFKVLKNLAKGVITSLKS |
19 |
Synthetic |
DRACP04525 |
|
FSLVNADQTT |
10 |
Synthetic |
DRACP04537 |
Leucocin A (1-18) |
KYYGNGVHCTKSGCSVNW |
18 |
Synthetic |
DRACP04538 |
LK-Leucocin A (9-14)-KL |
LKCTKSGCKL |
10 |
Synthetic |
DRACP04539 |
(LK)2-Leucocin A (9-14)-(KL)2 |
LKLKCTKSGCKLKL |
14 |
Synthetic |
DRACP04540 |
(LK)3-Leucocin A (9-14)-(KL)3 |
LKLKLKCTKSGCKLKLKL |
18 |
Synthetic |
DRACP04541 |
WK-Leucocin A (9-14)-KW |
WKCTKSGCKW |
10 |
Synthetic |
DRACP04542 |
(WK)3-Leucocin A (9-14)-(KW)3 |
WKWKWKCTKSGCKWKWKW |
18 |
Synthetic |
DRACP04543 |
VK-Leucocin A (9-14)-KV |
VKCTKSGCKV |
10 |
Synthetic |
DRACP04544 |
(VK)2-Leucocin A (9-14)-(KV)2 |
VKVKCTKSGCKVKV |
14 |
Synthetic |
DRACP04545 |
(VK)3-Leucocin A (9-14)-(KV)3 |
VKVKVKCTKSGCKVKVKV |
18 |
Synthetic |
DRACP04547 |
Spampcin (56鈥?6), Spa31 |
RRAAHGLLPRLRAPPPFHKRCVCLCRTAPPP |
31 |
Synthetic |
DRACP04564 |
Transmembrane protein (17-35), RCB-1 |
ARCCLVMPVPPFACVKFCS |
19 |
Synthetic |
DRACP04568 |
FM-Cathelicidin |
LKTKALNKLKQKLQAVGNLIGSVIKG |
26 |
Animalia |